How Mole Rats Fight Cancer

Blind mole rats resist cancer by killing cells that proliferate in a similar way to tumor cells.

Written byEdyta Zielinska
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Blind mole ratWikimedia, Bassem18 When cells taken from blind mole-rats proliferate too many times, the cells die en-masse, suggesting a possible mechanism for how these animals keep pre-cancerous cells from developing into full-fledged disease. The study, published last week (October 5) in the Proceedings of the National Academy of Sciences, could point to new insights into controlling cancer, according to the authors.

Blind mole-rats, like their relatives the impervious naked mole-rat, live relatively long lives—about 21 years—yet never develop cancer. Although previous research found a genetic basis for the naked mole-rat’s immunity to cancer, the blind mole-rat appears to use a different mechanism for fending off the disease. (Read more about the remarkable naked mole rat in “Underground Supermodels,” The Scientist, June 2012.)

The researchers cultured cells from two species of blind mole-rats that inhabit the Judean Mountains of Israel. After about 7 to 20 generations, the cultured cells died all at once, as a result of their release of interferon-beta (IFN-β), a protein involved in anti-cancer and innate immune protection. While the results suggest the cells were unable to replicate beyond a certain number, it is ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform